%0 Journal Article
%T The Practice of Medical Oncology in Morocco: The National Study of the Moroccan Group of Trialist in Medical Oncology (EVA-Onco)
%A Saber Boutayeb
%A Amina Taleb
%A Rizlane Belbaraka
%A Nabil Ismaili
%A Narjiss Berrada
%A Wafa Allam
%A Halima Abahsain
%A Naoufal Mellas
%A Saif Afkir
%A Omar Mesbahi
%A Mohammed Ichou
%A Hassan Errihani
%J ISRN Oncology
%D 2013
%R 10.1155/2013/341565
%X Objective. To determine the current shortfall of medical oncologists (MOs) and the projected supply. Background. Morocco, the medical oncology (MO) is a relatively new specialty. Medical oncology was recognized as a separate specialty in 1994 but the real taking-off was done only since the 2000s after the creation of the chair of medical oncology in the University of Rabat. The GRIOMM (Moroccan group of trialist in medical oncology) was created in 2011 and conducted its first study, EVA-onco, concerning the practice of medical oncology in Morocco in 2011. Design. EVA-onco is a prospective study concerning the practice of medical oncology in Morocco in 2011. Results. The entire public cancer centers completed the survey. There were no missing data. The number of medical oncologist per 100000/habitants in Morocco was 0.09. The average number of new patients seen per medical oncologist was 718 patients (ranging by state from 97 to 1875). The shortfall of MOs was estimated at 26 at least in 2011 according to the national recommendations. Conclusions. Since 2010, a national strategy to increase the capacity of MO workforce existed. The current shortfall of MO is expected to disappear in the future. 1. Introduction The cancer treatment is based on three primary disciplines: medical oncology, surgical oncology, and radiation oncology. The medical oncologist specializes in diagnosing and treating cancer using chemotherapy, hormonal therapy, biological therapy, and targeted therapy. Also, he may coordinate treatment given by other specialists and gives supportive care [1]. The treatment of cancer needs a multidisciplinary team but the medical treatment of cancer is becoming more complicated and more specialized so there is a real need for a medical oncologist specialty [1]. In Morocco, the MO is a relatively new specialty. MO was recognized as a separate specialty in 1994 but the real taking-off was done only since the 2000s after the creation of the chair of medical oncology in the University of Rabat. The AMFROM (Moroccan Association for training and research in medical oncology) was created in 2008 to assure a high-level of qualification for young oncologists and to improve the recognition of medical oncology. In the same way, the GRIOMM (Moroccan group of trialist in medical oncology) was created in 2011. Its first study is Eva-onco which is a national survey about the practice of medical oncology in the public health centers across Morocco. 2. Materiel and Methods EVA-onco is a prospective study concerning the practice of medical oncology in Morocco in 2011
%U http://www.hindawi.com/journals/isrn.oncology/2013/341565/